Home > Insider Trading > Filing (0001217234-22-000038)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1217234	Caredx Inc.	CDNA	Services-Medical Laboratories (8071)	943316839

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1688485	Reginald Seeto	C/O Caredx, Inc. 1 Tower Place, 9Th Floor South San Francisco CA 94080	See Remarks	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2022-02-02	3,182	$41.25	126,746	No	4	S	Direct
Common Stock	Acquisiton	2022-02-02	73,350	$0.00	200,096	No	4	A	Direct
Common Stock	Disposition	2022-02-03	2,388	$40.08	197,708	No	4	F	Direct
Common Stock	Disposition	2022-02-04	4,988	$40.34	192,720	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	A	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Acquisiton	2022-02-02	83,350	$0.00	83,350	$41.32

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
83,350		2032-02-02	No	4	A	Direct

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The reported securities are represented by restricted stock units, 1/4th of which shall vest on February 2, 2023 and 1/4th of which shall vest on each anniversary thereafter.
These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.10 to $40.57, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
1/4th of the shares subject to the option shall vest on February 2, 2023 and 1/48th of the shares subject to the option shall vest monthly thereafter.